Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04518670 · ClinicalTrials.gov registry record
Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)
A clinical trial, sponsored by Rapid Medical.
- Completed
- Registry status
- 90
- Enrollment target
NCT04518670 is a clinical trial that has completed, run by Rapid Medical. The registered enrollment target is 90 participants.
The verdict
NCT04518670 has completed, sponsored by Rapid Medical.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The Comaneci Embolization Assist Device is indicated for use in the neurovasculature as a temporary endovascular device used to assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm. A wide-necked intracranial aneurysm (IA) defines the neck width as ≥ 4 mm or a dome-to-neck ratio \< 2. The objective of the Postmarket Surveillance Plan is to assess safety and performance as used in postmarket clinical practice in the U.S.
Interventions
- DEVICE Comaneci Embolization Assist Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2024-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04518670
The ClinicalTrials.gov registry entry for NCT04518670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rapid Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comaneci Embolization Assist Device is the first listed.
NCT04518670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04518670 about?
NCT04518670 is a clinical study titled "Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)". The Comaneci Embolization Assist Device is indicated for use in the neurovasculature as a temporary endovascular device used to assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm. A wide-necked intracranial aneurysm (IA) defines the neck width as ≥ 4 mm o...
What is the current status of trial NCT04518670?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2020-11-24. Estimated completion is 2024-07-07.
What interventions are being tested in trial NCT04518670?
The interventions under investigation include: Comaneci Embolization Assist Device (DEVICE).
Who is sponsoring clinical trial NCT04518670?
This trial is sponsored by Rapid Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.